Wellcome Trust Centre for Human Genetics, Cellular Imaging, University of Oxford, Oxford, UK.
HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702, USA.
Trends Mol Med. 2017 Oct;23(10):932-944. doi: 10.1016/j.molmed.2017.08.005. Epub 2017 Sep 9.
HIV-1 disseminates to diverse tissues through different cell types and establishes long-lived reservoirs. The exact cellular compartment where fusion occurs differs depending on the cell type and mode of viral transmission. This implies that HIV-1 may modulate a number of common host cell factors in different cell types. In this review, we evaluate recent advances on the host cell factors that play an important role in HIV-1 entry and fusion. New insights from restriction factors inhibiting virus-cell fusion in vitro may contribute to the development of future therapeutic interventions. Collectively, novel findings underline the need for potent, host-directed therapies that disrupt the earliest stages of the virus life cycle and preclude the emergence of resistant viral variants.
HIV-1 通过不同的细胞类型传播到不同的组织,并建立了长期存在的储库。融合发生的确切细胞区室取决于细胞类型和病毒传播方式。这意味着 HIV-1 可能在不同的细胞类型中调节许多常见的宿主细胞因子。在这篇综述中,我们评估了在 HIV-1 进入和融合中起重要作用的宿主细胞因子的最新进展。在体外抑制病毒-细胞融合的限制因子的新见解可能有助于开发未来的治疗干预措施。总的来说,新的发现强调了需要有效的、针对宿主的治疗方法,以破坏病毒生命周期的早期阶段,并防止耐药病毒变异的出现。